CN Stock MarketDetailed Quotes
300391 Changjiang Pharmaceutical Group
- 2.31
- -0.10-4.15%
Market Closed Jun 28 15:00 CST
809.28MMarket Cap-1284P/E (TTM)
2.48High2.28Low88.93KlotVolume2.48Open2.41Pre Close21.19MTurnover2.54%Turnover RatioLossP/E (Static)350.34MShares8.9652wk High5.49P/B809.28MFloat Cap2.2452wk Low2.89Limit Up350.34MShs Float28.95Historical High1.93Limit Down8.30%Amplitude2.24Historical Low--Dividend TTM2.38Avg Price47.22KlotAsk--Div YieldTTM100Lot Size37.89KlotBid
Changjiang Pharmaceutical Group Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -56.80%59.09M | -25.86%1.2B | -28.17%1.02B | -52.01%476.01M | -74.92%136.79M | -31.61%1.62B | -21.76%1.42B | -23.56%991.85M | -30.53%545.4M | 94.48%2.36B |
| Operating revenue | -56.80%59.09M | -25.86%1.2B | -28.17%1.02B | -52.01%476.01M | -74.92%136.79M | -31.61%1.62B | -21.76%1.42B | -23.56%991.85M | -30.53%545.4M | 94.48%2.36B |
| Other operating revenue | ---- | 47.17%8.15M | ---- | 74.25%5.58M | ---- | -59.75%5.54M | ---- | -59.30%3.2M | ---- | 16.10%13.76M |
| Total operating cost | -44.39%89.75M | -20.61%1.18B | -21.40%1.01B | -47.82%473.82M | -66.56%161.38M | -29.73%1.49B | -20.04%1.28B | -20.11%908.11M | -29.35%482.57M | 81.40%2.12B |
| Operating cost | -56.54%54.6M | -21.05%1B | -22.29%859.11M | -47.99%397.4M | -69.17%125.65M | -30.53%1.27B | -21.06%1.11B | -23.38%764.04M | -33.33%407.5M | 92.02%1.83B |
| Operating tax surcharges | -15.94%554.83K | -47.23%3.71M | -56.84%2.41M | -61.37%1.73M | -69.00%660.02K | -18.46%7.03M | -16.09%5.59M | -0.98%4.48M | -10.96%2.13M | 42.47%8.63M |
| Operating expense | 7.63%5.1M | -29.04%23.59M | -20.04%24.82M | -61.33%9.81M | -67.60%4.74M | -48.32%33.24M | -38.38%31.04M | -19.18%25.36M | -14.28%14.63M | 53.92%64.33M |
| Administration expense | -11.16%16.09M | -18.40%84.11M | -30.43%59.53M | -40.24%40.54M | -48.31%18.1M | -26.44%103.08M | -11.84%85.57M | -0.47%67.84M | 3.15%35.03M | 29.44%140.14M |
| Financial expense | 21.64%12.42M | 20.15%60.97M | 58.72%57.38M | -26.01%20.68M | -32.47%10.21M | 27.92%50.74M | 48.98%36.15M | 69.94%27.94M | 103.74%15.12M | 127.40%39.67M |
| -Interest expense (Financial expense) | 34.93%12.79M | 9.43%61.31M | 44.17%59.24M | -27.64%21.67M | -33.35%9.48M | 47.65%56.03M | 73.61%41.09M | 87.02%29.95M | 179.99%14.22M | 143.88%37.95M |
| -Interest Income (Financial expense) | -1,033.71%-213.87K | 74.26%-97.15K | 79.33%-72.24K | 84.88%-29.26K | 75.29%-18.87K | 55.81%-377.46K | 24.75%-349.43K | 53.78%-193.48K | 68.01%-76.34K | 58.53%-854.15K |
| Research and development | -51.33%978.78K | -70.26%7.66M | -69.77%6.14M | -80.14%3.66M | -75.35%2.01M | -34.56%25.76M | -24.88%20.3M | -2.94%18.45M | -25.43%8.16M | -8.79%39.36M |
| Credit Impairment Loss | -533.01%-47.02M | -244.10%-195.9M | -133.68%-102.55M | -153.35%-48.56M | 43.03%-7.43M | 14.52%-56.93M | -17.60%-43.88M | -28.62%-19.17M | -39,614.15%-13.04M | -626.18%-66.6M |
| Asset Impairment Loss | ---- | -984.45%-559.7M | -510.85%-106.89M | -351.54%-78.87M | ---203.69K | -156.11%-51.61M | -555.02%-17.5M | -1,241.49%-17.47M | ---- | -1,010.35%-20.15M |
| Other net revenue | -542.18%-46.78M | -1,359.69%-685.67M | -7,739.83%-207.99M | -285.30%-126.42M | 35.50%-7.28M | 29.68%-46.97M | 83.20%-2.65M | -2,524.77%-32.81M | -218.24%-11.29M | -658.07%-66.8M |
| Fair value change income | ---- | --67.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | ---- | ---- | ---- | ---- | ---- | 5,332.45%55.19M | 5,294,936.94%53.47M | -59,101.29%-595.75K | -49,731.43%-501.14K | 57.05%-1.05M |
| Asset deal income | ---- | 58.68%78.55K | -678.28%-304.35K | -981.98%-464.19K | ---- | -97.64%49.5K | -98.33%52.63K | -98.36%52.63K | -100.11%-3.61K | 163.66%2.1M |
| Other revenue | -29.40%245.69K | -65.09%2.21M | -66.35%1.75M | -66.12%1.48M | -84.54%348.02K | -66.52%6.33M | -64.14%5.21M | -62.08%4.37M | -64.82%2.25M | -34.12%18.91M |
| Operating profit | -142.95%-77.43M | -937.70%-669.71M | -243.94%-195.51M | -343.88%-124.22M | -161.84%-31.87M | -54.81%79.95M | -30.90%135.83M | -68.61%50.93M | -53.85%51.54M | 201.02%176.92M |
| Add:Non operating Income | -77.94%5.15K | -92.27%764.07K | 886.00%81.28M | 897.56%81.09M | -88.61%23.35K | 542.27%9.89M | 1,605.14%8.24M | 2,208.39%8.13M | 6.53%204.99K | 744.88%1.54M |
| Less:Non operating expense | 4,719.49%3.69M | -33.01%12.06M | -88.66%1.18M | -96.60%334.95K | -84.64%76.61K | -10.55%18.01M | 261.14%10.4M | 878.27%9.85M | 128.48%498.65K | 3,628.10%20.13M |
| Total profit | -154.09%-81.12M | -1,048.14%-681.01M | -186.33%-115.4M | -188.32%-43.46M | -162.30%-31.93M | -54.63%71.83M | -31.16%133.67M | -69.55%49.21M | -54.10%51.25M | 171.04%158.32M |
| Less:Income tax cost | ---- | -3.41%26.32M | -27.40%22.19M | -116.90%-5.86M | -209.61%-1.11M | 2,807.50%27.25M | 756.73%30.56M | 1,045.65%34.64M | -81.18%1.02M | 87.22%-1.01M |
| Net profit | FPtoL-81.12M | SL-707.33M | SL-137.59M | SL-37.6M | SL-30.81M | -72.03%44.57M | -45.90%103.11M | -90.81%14.57M | -52.73%50.23M | 140.35%159.33M |
| Net profit from continuing operation | -163.26%-81.12M | -1,686.94%-707.33M | -298.21%-204.38M | -205.32%-15.34M | -161.34%-30.81M | -72.03%44.57M | -45.90%103.11M | -90.81%14.57M | -52.73%50.23M | 140.35%159.33M |
| Less:Minority Profit | -327.93%-33.61M | -249.87%-101.68M | -128.72%-21.74M | -124.41%-13.39M | -122.07%-7.86M | -38.45%67.85M | -19.40%75.68M | -26.48%54.84M | -24.04%35.59M | 169.03%110.23M |
| Net profit of parent company owners | -106.92%-47.51M | -2,502.35%-605.65M | -522.43%-115.85M | 39.88%-24.22M | -256.75%-22.96M | -147.40%-23.27M | -71.64%27.43M | -147.95%-40.28M | -75.35%14.65M | 93.94%49.1M |
| Earning per share | ||||||||||
| Basic earning per share | -107.02%-0.1356 | -2,503.61%-1.7288 | -522.35%-0.3307 | 39.91%-0.0691 | -256.70%-0.0655 | -147.36%-0.0664 | -71.63%0.0783 | -147.96%-0.115 | -75.35%0.0418 | 93.91%0.1402 |
| Diluted earning per share | -107.02%-0.1356 | -2,503.61%-1.7288 | -522.35%-0.3307 | 39.91%-0.0691 | -256.70%-0.0655 | -147.36%-0.0664 | -71.63%0.0783 | -147.96%-0.115 | -75.35%0.0418 | 93.91%0.1402 |
| Other composite income | 170.80%5.39K | 145.07%5.39K | -661.84%-42.9K | 99.82%-24.19K | ||||||
| Other composite income of parent company owners | ---- | ---- | ---- | ---- | ---- | ---- | 170.80%5.39K | 145.07%5.39K | -661.84%-42.9K | 99.82%-24.19K |
| Total composite income | -163.26%-81.12M | -1,686.94%-707.33M | -233.44%-137.59M | -358.03%-37.6M | -161.39%-30.81M | -72.02%44.57M | -45.90%103.11M | -90.81%14.57M | -52.77%50.19M | 202.99%159.31M |
| Total composite income of parent company owners | -106.92%-47.51M | -2,502.35%-605.65M | -522.35%-115.85M | 39.87%-24.22M | -257.22%-22.96M | -147.42%-23.27M | -71.63%27.43M | -147.95%-40.27M | -75.42%14.6M | 322.85%49.08M |
| Total composite income of minority owners | -327.93%-33.61M | -249.87%-101.68M | -128.72%-21.74M | -124.41%-13.39M | -122.07%-7.86M | -38.45%67.85M | -19.40%75.68M | -26.48%54.84M | -24.04%35.59M | 169.03%110.23M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | China Audit Asia Pacific Certified Public Accountants (Special General Partnership) | -- | -- | -- | China Audit Asia Pacific Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg